This phase 3 randomized clinical trial uses prespecified sensitivity analyses from 1717 men with chemotherapy-naive metastatic castration-resistant prostate cancer to assess the clinical relevance of the Prostate Cancer Working Group 2 definition of radiographic progression-free survival.
http://ift.tt/2Fz6geT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου